Amy Sullivan

1.1k total citations · 1 hit paper
16 papers, 380 citations indexed

About

Amy Sullivan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Amy Sullivan has authored 16 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Amy Sullivan's work include Cancer Immunotherapy and Biomarkers (7 papers), Cancer Genomics and Diagnostics (4 papers) and CAR-T cell therapy research (3 papers). Amy Sullivan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Cancer Genomics and Diagnostics (4 papers) and CAR-T cell therapy research (3 papers). Amy Sullivan collaborates with scholars based in United States, France and Finland. Amy Sullivan's co-authors include Patrick Danaher, Irena Pekker, Alessandra Cesano, Sarah Warren, Brett Wallden, Josue Samayoa, Rongze Lu, Francesco M. Marincola, Torsten O. Nielsen and Saranya Chumsri and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Amy Sullivan

15 papers receiving 375 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

2018 294 citations Patrick Danaher, Sarah Warren et al. Journal for ImmunoTherapy of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Sullivan United States	6	258	160	124	110	87	16	380
Yalun Li China	12	164 0.6×	163 1.0×	82 0.7×	117 1.1×	89 1.0×	39	412
Ignazio Martellucci Italy	11	280 1.1×	110 0.7×	67 0.5×	64 0.6×	73 0.8×	16	356
Francesca Sparano Italy	9	219 0.8×	103 0.6×	78 0.6×	113 1.0×	65 0.7×	19	369
Casilda Llácer Spain	7	334 1.3×	77 0.5×	163 1.3×	103 0.9×	70 0.8×	11	477
Zuyi Yang China	10	119 0.5×	167 1.0×	61 0.5×	184 1.7×	125 1.4×	20	350
Yuto Yasuda Japan	10	221 0.9×	172 1.1×	59 0.5×	121 1.1×	62 0.7×	35	346
Longgang Cui China	7	297 1.2×	159 1.0×	65 0.5×	61 0.6×	72 0.8×	17	383
Joon Young Hur South Korea	10	238 0.9×	84 0.5×	139 1.1×	54 0.5×	47 0.5×	26	346
Daniele Pozzessere Italy	14	230 0.9×	175 1.1×	103 0.8×	114 1.0×	60 0.7×	24	426
S. Mariucci Italy	9	198 0.8×	63 0.4×	107 0.9×	146 1.3×	82 0.9×	18	341

Countries citing papers authored by Amy Sullivan

Since Specialization

Citations

This map shows the geographic impact of Amy Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Sullivan more than expected).

Fields of papers citing papers by Amy Sullivan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Sullivan. The network helps show where Amy Sullivan may publish in the future.

Co-authorship network of co-authors of Amy Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Sullivan. A scholar is included among the top collaborators of Amy Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Sullivan. Amy Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Shomali, Maysoun, Zhuyan Guo, Jane Cheng, et al.. (2022). Abstract P4-02-08: Amcenestrant in combination with CDK4/6 inhibitor palbociclib demonstrates synergistic anti-tumor activity in ER+ endocrine-resistant breast cancer xenograft models. Cancer Research. 82(4_Supplement). P4–2. 2 indexed citations

Kurosky, Samantha K., et al.. (2021). Abstract PS11-21: First-line treatment trends in metastatic breast cancer before and at the early stage of the COVID-19 pandemic in the United States. Cancer Research. 81(4_Supplement). PS11–21.

Asleh, Karama, Heather Ann Brauer, Amy Sullivan, et al.. (2020). Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial. Clinical Cancer Research. 26(11). 2603–2614. 20 indexed citations

Sullivan, Amy, David M. Dranow, P.S. Horanyi, et al.. (2019). Crystal structures of thiamine monophosphate kinase from Acinetobacter baumannii in complex with substrates and products. Scientific Reports. 9(1). 4392–4392. 2 indexed citations

Ordentlich, Peter, Lei Wang, David Tamang, et al.. (2019). Abstract CT041: Identification of gene signatures associated with response in a Phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy. Cancer Research. 79(13_Supplement). CT041–CT041. 1 indexed citations

Ordentlich, Peter, Lei Wang, David Tamang, et al.. (2019). Abstract CT041: Identification of gene signatures associated with response in a Phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy. Clinical Trials. CT041–CT041. 1 indexed citations

Rutella, Sergio, Jayakumar Vadakekolathu, Stephen Reeder, et al.. (2019). Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+ gastroesophageal adenocarcinoma (GEA). Annals of Oncology. 30. v38–v39. 1 indexed citations

Danaher, Patrick, Sarah Warren, Rongze Lu, et al.. (2018). Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA). Journal for ImmunoTherapy of Cancer. 6(1). 63–63. 294 indexed citations breakdown →

Rutella, Sergio, S. Church, Jayakumar Vadakekolathu, et al.. (2018). Adaptive Immune Gene Signatures Correlate with Response to Flotetuzumab, a CD123 × CD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia. Blood. 132(Supplement 1). 444–444. 11 indexed citations

10.

Church, S., Irena Pekker, Naeem Dowidar, et al.. (2018). Validating critical analytical variables of a multiplexed gene expression assay measuring tumor inflammation designed to predict response to anti-PD1 therapy.. Journal of Clinical Oncology. 36(5_suppl). 203–203. 2 indexed citations

11.

Haft, Daniel H., Stephen J. Mayclin, Amy Sullivan, et al.. (2017). Mycofactocin-associated mycobacterial dehydrogenases with non-exchangeable NAD cofactors. Scientific Reports. 7(1). 41074–41074. 17 indexed citations

12.

Wallden, Brett, Irena Pekker, Naeem Dowidar, et al.. (2017). Verification of the analytical performance of a molecular diagnostic for response to anti-PD1 therapy on the nCounter Dx Analysis System.. Journal of Clinical Oncology. 35(7_suppl). 8–8. 2 indexed citations

13.

Chen, Ning, Patrick Danaher, Brett Wallden, et al.. (2016). Analytical Validation of the nCounter®-based Lymphoma Subtyping Test (LST) for Cell-of-Origin (COO) Identification in Formalin-Fixed Paraffin-Embedded (FFPE) Diffuse Large B-Cell Lymphoma (DLBCL) Specimens. Blood. 128(22). 2933–2933. 2 indexed citations

14.

Wallden, Brett, Irena Pekker, Naeem Dowidar, et al.. (2016). Development and analytical performance of a molecular diagnostic for anti-PD1 response on the nCounter Dx Analysis System.. Journal of Clinical Oncology. 34(15_suppl). 3034–3034. 16 indexed citations

15.

Fairman, J.W., Steve Barnes, Amy Sullivan, et al.. (2015). Structures of prostaglandin F synthase from the protozoaLeishmania majorandTrypanosoma cruziwith NADP. Acta Crystallographica Section F Structural Biology Communications. 71(5). 609–614. 8 indexed citations

16.

Lammers, Philip E., Snjezana Zaja‐Milatovic, Amy Sullivan, et al.. (2012). Somatic mutation spectrum of non-small cell lung cancers (NSCLCs) from African Americans (AAs).. Journal of Clinical Oncology. 30(15_suppl). 6038–6038. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact